Cart
sales@molnova.com
Cibisatamab
CAS No. 1855925-27-7
Cibisatamab( —— )
Catalog No. M36660 CAS No. 1855925-27-7
Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 854 | Get Quote |
|
| 5MG | 943 | Get Quote |
|
| 10MG | 1568 | Get Quote |
|
| 25MG | 2263 | Get Quote |
|
| 50MG | 3054 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCibisatamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionCibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.
-
DescriptionCibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1855925-27-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Reyes Gonzalez-Exposito, et al. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. J Immunother Cancer. 2019 Apr 15;7(1):101. ?
molnova catalog
related products
-
3-(Methylthio)propio...
3-methylthiopropionate is one of the metabolites of methionine (especially of D-methionine). Cultures of Streptomyces lincolnensis accumulated 3-methylthioacrylic acid in amounts directly related to the concentration of methionine in the medium. The first intermediate in the pathway may be the keto acid which is then oxidatively decarboxylated to 3-methylthiopropionic acid.
-
Z-DQMD-FMK
Caspase-3 inhibitor. Inhibits MG 132-induced small cell lung cancer cell death in vitro.
-
Quinfamide
Quinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
